TechnologyTracking
China's export control revisions: how will AI, biomedicine, and solar tech exports be affected?
China has opened public consultation on export control revisions covering 40 technologies in AI, biomedicine, and solar PV; how will temporary registration management affect exports of these technologies?
Watching: 修订尚在征求意见阶段，最终目录内容和临时登记管理的具体操作细则未公布，对技术出口的实际影响存在不确定性。
Current read
On Oct 16, 2026, MOFCOM and MOST sought public comments on revising the export control catalog, proposing to add 40 AI, biopharma, and solar technologies and implement interim registration management.
According to the Oct 16, 2026 joint announcement No. 48 by MOFCOM and MOST, 40 AI, biopharma, and solar technologies are proposed for inclusion in the export control catalog, with interim registration management effective immediately and public comments solicited. The announcement cites foreign trade laws, but specific scope, registration procedures, and final catalog details are not disclosed. The evidence does not specify how registration will affect exports or when the final revised catalog will be issued.
How we read it
The announcement proposes adding 40 technologies to the catalog and implementing interim registration, but no operational details are provided.
The evidence does not specify the registration process, scope, or practical impact on exports.
Earlier updates
- — Public tracking started; no independent probability estimate yet.; Starting public context: The Ministry of Commerce and Ministry of Science and Technology on October 16 opened public consultation on revisions to the Catalogue of Technologies Prohibited or Restricted from Export, covering 40 technologies across artificial intelligence, biomedicine and solar photovoltaics, and imposed temporary registration management on related technology exports.
- — On Oct 16, 2026, MOFCOM and MOST sought public comments on revising the export control catalog, proposing to add 40 AI, biopharma, and solar technologies and implement interim registration management.; According to the Oct 16, 2026 joint announcement No. 48 by MOFCOM and MOST, 40 AI, biopharma, and solar technologies are proposed for inclusion in the export control catalog, with interim registration management effective immediately and public comments solicited. The announcement cites foreign trade laws, but specific scope, registration procedures, and final catalog details are not disclosed. The evidence does not specify how registration will affect exports or when the final revised catalog will be issued.